DK20886D0 - Imidazolderivater, deres fremstilling og terapeutiske anvendelse - Google Patents

Imidazolderivater, deres fremstilling og terapeutiske anvendelse

Info

Publication number
DK20886D0
DK20886D0 DK20886A DK20886A DK20886D0 DK 20886 D0 DK20886 D0 DK 20886D0 DK 20886 A DK20886 A DK 20886A DK 20886 A DK20886 A DK 20886A DK 20886 D0 DK20886 D0 DK 20886D0
Authority
DK
Denmark
Prior art keywords
sup
preparation
therapeutic application
imidazold
derivatives
Prior art date
Application number
DK20886A
Other languages
English (en)
Other versions
DK20886A (da
Inventor
Isao Kawamoto
Rokuro Endo
Keiichi Matsuda
Shigeru Ushiyama
Takeshi Oshima
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of DK20886D0 publication Critical patent/DK20886D0/da
Publication of DK20886A publication Critical patent/DK20886A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DK20886A 1985-01-16 1986-01-16 Imidazolderivater, deres fremstilling og terapeutiske anvendelse DK20886A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP405585 1985-01-16

Publications (2)

Publication Number Publication Date
DK20886D0 true DK20886D0 (da) 1986-01-16
DK20886A DK20886A (da) 1986-07-17

Family

ID=11574190

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20886A DK20886A (da) 1985-01-16 1986-01-16 Imidazolderivater, deres fremstilling og terapeutiske anvendelse

Country Status (13)

Country Link
US (1) US4894385A (da)
EP (1) EP0188383B1 (da)
JP (1) JPH0625141B2 (da)
KR (1) KR930004674B1 (da)
AT (1) ATE104967T1 (da)
AU (1) AU582206B2 (da)
CA (1) CA1296009C (da)
DE (1) DE3689807T2 (da)
DK (1) DK20886A (da)
ES (2) ES8706125A1 (da)
FI (1) FI90866C (da)
NO (1) NO166445C (da)
ZA (1) ZA86286B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925953A (en) * 1987-12-09 1990-05-15 Ss Pharmaceutical Co., Ltd. Imidazole derivative
US5308860A (en) * 1993-01-15 1994-05-03 Rohm And Haas Company Cyanosulfonylethyltriazoles
JP2002167378A (ja) 2000-09-22 2002-06-11 Ss Pharmaceut Co Ltd イミダゾール誘導体又はその塩
JP2006347882A (ja) * 2003-09-02 2006-12-28 Ss Pharmaceut Co Ltd ベンジルアルコール誘導体又はその塩

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001654B1 (de) * 1977-10-13 1981-07-22 Siegfried Aktiengesellschaft Imidazolyläthyl-oxyalkoxy-Derivate und ihre Thio-Analoge, pharmazeutische Zubereitungen mit diesen Stoffen und Verfahren zu ihrer Herstellung
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
DK471479A (da) * 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
JPS56120670A (en) * 1980-02-27 1981-09-22 Teijin Ltd 1-substituted imidazole derivative and its preparation
GB8400254D0 (en) * 1984-01-06 1984-02-08 Searle & Co Substituted alklidene imidazoles

Also Published As

Publication number Publication date
NO166445B (no) 1991-04-15
AU582206B2 (en) 1989-03-16
ES8801636A1 (es) 1988-02-16
KR860005793A (ko) 1986-08-13
DE3689807D1 (de) 1994-06-01
DK20886A (da) 1986-07-17
CA1296009C (en) 1992-02-18
FI860210A0 (fi) 1986-01-16
ES8706125A1 (es) 1987-06-01
FI90866B (fi) 1993-12-31
DE3689807T2 (de) 1994-08-25
FI90866C (fi) 1994-04-11
JPH0625141B2 (ja) 1994-04-06
ES550972A0 (es) 1987-06-01
NO860114L (no) 1986-07-17
JPS61267557A (ja) 1986-11-27
EP0188383A3 (en) 1988-06-22
ES557436A0 (es) 1988-02-16
US4894385A (en) 1990-01-16
KR930004674B1 (ko) 1993-06-03
ATE104967T1 (de) 1994-05-15
FI860210L (fi) 1986-07-17
AU5242586A (en) 1986-07-24
NO166445C (no) 1991-08-07
EP0188383A2 (en) 1986-07-23
ZA86286B (en) 1986-09-24
EP0188383B1 (en) 1994-04-27

Similar Documents

Publication Publication Date Title
DK165003C (da) Chlorsulfat
SE8605063D0 (sv) Derivatives of cyclohexane
DE3581465D1 (de) Pyridazinonderivate, deren herstellung und verwendung.
ATE74110T1 (de) Kristallinische gallophosphatzusammensetzungen.
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
NZ208954A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
ATE86860T1 (de) Praeparat gegen ulcus.
DK45987D0 (da) Thianaphthenderivater, deres fremstilling og anvendelse
AU582206B2 (en) Imidazole derivatives,their preparation and therapeutic use
MY110092A (en) Butyric acid derivatives
DE3268541D1 (en) Benzodioxane-imidazoline compounds, their preparation and use
ES2000058A6 (es) Un procedimiento para preparar deircados de ester de fosfato
ATE78032T1 (de) 2-pyridylessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE68905796D1 (de) Chromoglycinsaeure-natriumsalz enthaltende aerosolzubereitungen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment